157 related articles for article (PubMed ID: 24096962)
21. Cerebrotendinous xanthomatosis.
Björkhem I
Curr Opin Lipidol; 2013 Aug; 24(4):283-7. PubMed ID: 23759795
[TBL] [Abstract][Full Text] [Related]
22. Clinical and molecular diagnosis of cerebrotendinous xanthomatosis with a review of the mutations in the CYP27A1 gene.
Gallus GN; Dotti MT; Federico A
Neurol Sci; 2006 Jun; 27(2):143-9. PubMed ID: 16816916
[TBL] [Abstract][Full Text] [Related]
23. Unique patient with cerebrotendinous xanthomatosis. Evidence for presence of a defect in a gene that is not identical to sterol 27-hydroxylase.
Hansson M; Olin M; Floren CH; von Bahr S; van't Hooft F; Meaney S; Eggertsen G; Björkhem I
J Intern Med; 2007 May; 261(5):504-10. PubMed ID: 17444890
[TBL] [Abstract][Full Text] [Related]
24. Cortisol metabolism in depressed patients and healthy controls.
Römer B; Lewicka S; Kopf D; Lederbogen F; Hamann B; Gilles M; Schilling C; Onken V; Frankhauser P; Deuschle M
Neuroendocrinology; 2009; 90(3):301-6. PubMed ID: 19713693
[TBL] [Abstract][Full Text] [Related]
25. Cerebrotendinous xanthomatosis: an inborn error in bile acid synthesis with defined mutations but still a challenge.
Björkhem I; Hansson M
Biochem Biophys Res Commun; 2010 May; 396(1):46-9. PubMed ID: 20494109
[TBL] [Abstract][Full Text] [Related]
26. In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.
Mai K; Kullmann V; Bobbert T; Maser-Gluth C; Möhlig M; Bähr V; Pfeiffer AF; Spranger J; Diederich S
Clin Endocrinol (Oxf); 2005 Oct; 63(4):442-9. PubMed ID: 16181237
[TBL] [Abstract][Full Text] [Related]
27. Detailed analysis of cortisol, cortisone and their tetrahydro- and allo-tetrahydrometabolites in human urine by LC-MS/MS.
Kosicka K; Siemiątkowska A; Pałka D; Szpera-Goździewicz A; Bręborowicz GH; Główka FK
J Pharm Biomed Anal; 2017 Jun; 140():174-181. PubMed ID: 28359965
[TBL] [Abstract][Full Text] [Related]
28. In vivo 11beta-HSD-2 activity: variability, salt-sensitivity, and effect of licorice.
Ferrari P; Sansonnens A; Dick B; Frey FJ
Hypertension; 2001 Dec; 38(6):1330-6. PubMed ID: 11751713
[TBL] [Abstract][Full Text] [Related]
29. Effect of Cyp27A1 gene dosage on atherosclerosis development in ApoE-knockout mice.
Zurkinden L; Solcà C; Vögeli IA; Vogt B; Ackermann D; Erickson SK; Frey FJ; Sviridov D; Escher G
FASEB J; 2014 Mar; 28(3):1198-209. PubMed ID: 24327605
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms for the species difference between mouse and pig oocytes in their sensitivity to glucorticoids.
Gong S; Sun GY; Zhang M; Yuan HJ; Zhu S; Jiao GZ; Luo MJ; Tan JH
Biol Reprod; 2017 May; 96(5):1019-1030. PubMed ID: 28419184
[TBL] [Abstract][Full Text] [Related]
31. A novel mutation in the sterol 27-hydroxylase gene of a woman with autosomal recessive cerebrotendinous xanthomatosis.
Schneider H; Lingesleben A; Vogel HP; Garuti R; Calandra S
Orphanet J Rare Dis; 2010 Oct; 5():27. PubMed ID: 20925952
[TBL] [Abstract][Full Text] [Related]
32. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats.
Livingstone DE; Jones GC; Smith K; Jamieson PM; Andrew R; Kenyon CJ; Walker BR
Endocrinology; 2000 Feb; 141(2):560-3. PubMed ID: 10650936
[TBL] [Abstract][Full Text] [Related]
33. Cholesterol deregulation induced by chronic corticosterone (CORT) stress in pectoralis major of broiler chickens.
Duan Y; Fu W; Wang S; Ni Y; Zhao R
Comp Biochem Physiol A Mol Integr Physiol; 2014 Oct; 176():59-64. PubMed ID: 25038300
[TBL] [Abstract][Full Text] [Related]
34. Cerebrotendinous xanthomatosis, a metabolic disease with different neurological signs: two case reports.
Di Taranto MD; Gelzo M; Giacobbe C; Gentile M; Marotta G; Savastano S; Dello Russo A; Fortunato G; Corso G
Metab Brain Dis; 2016 Oct; 31(5):1185-8. PubMed ID: 27225395
[TBL] [Abstract][Full Text] [Related]
35. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
Harno E; Cottrell EC; Keevil BG; DeSchoolmeester J; Bohlooly-Y M; Andersén H; Turnbull AV; Leighton B; White A
Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
[TBL] [Abstract][Full Text] [Related]
36. Expression of renal 11beta-hydroxysteroid dehydrogenase type 2 is decreased in patients with impaired renal function.
Quinkler M; Zehnder D; Lepenies J; Petrelli MD; Moore JS; Hughes SV; Cockwell P; Hewison M; Stewart PM
Eur J Endocrinol; 2005 Aug; 153(2):291-9. PubMed ID: 16061836
[TBL] [Abstract][Full Text] [Related]
37. Role of 11βHSD type 2 enzyme activity in essential hypertension and children with chronic kidney disease (CKD).
Mongia A; Vecker R; George M; Pandey A; Tawadrous H; Schoeneman M; Muneyyirci-Delale O; Nacharaju V; Ten S; Bhangoo A
J Clin Endocrinol Metab; 2012 Oct; 97(10):3622-9. PubMed ID: 22872687
[TBL] [Abstract][Full Text] [Related]
38. The first cerebrotendinous xanthomatosis family from Argentina: a new mutation in CYP27A1 gene.
Szlago M; Gallus GN; Schenone A; Patiño ME; Sfaelo Z; Rufa A; Da Pozzo P; Cardaioli E; Dotti MT; Federico A
Neurology; 2008 Jan; 70(5):402-4. PubMed ID: 18227423
[No Abstract] [Full Text] [Related]
39. Reduced 11beta-hydroxysteroid dehydrogenase activity in patients with the nephrotic syndrome.
Vogt B; Dick B; N'Gankam V; Frey FJ; Frey BM
J Clin Endocrinol Metab; 1999 Feb; 84(2):811-4. PubMed ID: 10022459
[TBL] [Abstract][Full Text] [Related]
40. Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies.
Moore JS; Monson JP; Kaltsas G; Putignano P; Wood PJ; Sheppard MC; Besser GM; Taylor NF; Stewart PM
J Clin Endocrinol Metab; 1999 Nov; 84(11):4172-7. PubMed ID: 10566668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
